Category: Markets
Published: 2026-07-06T14:46:21.000Z
Medtech companies engaged in significant merger and acquisition activity during the first half of 2026, building on previous high deal volumes. This period saw $36.5 billion in acquisitions, with companies like Boston Scientific, Medtronic, and Stryker making strategic moves to enter fast-growing markets or divest from slower areas. The top deal was Boston Scientific's $14.5 billion acquisition of Penumbra, alongside other notable transactions by Danaher, Roche, and Agilent.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.